Evidence map›Paper›PMID 9529046›Full record

ArticleInfection and immunity1998

Glycosphingolipids as novel targets for T-cell suppression by the B subunit of recombinant heat-labile enterotoxin.

R L Truitt, C Hanke, J Radke, R Mueller, J T Barbieri

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R L TruittDepartment of Pediatrics, Cancer Center, Medical College of Wisconsin, Milwaukee 53226, USA. rtruitt@mcw.edu
C Hanke
J Radke
R Mueller
J T Barbieri
Pediatrics and Genetics · USMedical College of Wisconsin · US

Funding

Mechanisms of Bacterial Toxin ActionR01AI030162 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T · 1990 to 2019
$6.7M
RLTB--A NOVEL IMMUNOMODULATORY AGENT FOR USE IN BMTR01CA073738 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI TRUITT, ROBERT L · 1997 to 1999
–
NCI NIH HHS CA73738NIAID NIH HHS AI30162NIAID NIH HHS R01 AI030162
6 · The paper itself

Abstract

Heat-labile enterotoxin subunit B (LTB) is a noncatalytic protein derived from Escherichia coli that binds to ganglioside GM1, a glycosphingolipid on the surface of mammalian cells. In this study, the effects of recombinant LTB (rLTB) on murine lymphocytes were examined in vitro. T and B cells readily bound fluorescein isothiocyanate-labeled rLTB. CD8+ T cells bound twice as much as CD4+ T cells and B cells. Exposure of T-cell subsets and B cells to rLTB abrogated mitogen-driven proliferation. CD8+ T cells were more susceptible to rLTB than either CD4+ T cells or B cells. There were differences in the sensitivity of lymphocytes from various strains of mice to rLTB. This was attributed to qualitative and quantitative differences in the CD4+ T cells. rLTB induced apoptosis in both T-cell subsets, but the level was significantly higher in CD8+ T cells. Apoptosis peaked at around 8 h after exposure to rLTB and incubation at 37 degrees C. Binding to ganglioside GM1 was essential for suppression, since rLTB/G33D, a mutant which does not bind GM1, failed to inhibit proliferation or induce apoptosis. Naive T cells, which were acutely sensitive to rLTB, became more resistant after activation. Conversely, activated T cells regained their sensitivity to rLTB when they reverted back to a resting state. A 1-h pulse with rLTB was sufficient to inhibit T-cell proliferation and cytotoxic-T-lymphocyte generation in primary mixed lymphocyte reaction cultures. CD8+ T cells were preferentially depleted in these cultures. rLTB also induced functional modifications in T cells as indicated by inhibition of gamma interferon secretion after polyclonal activation. Thus, rLTB may have immunomodulatory properties independent of its ability to induce apoptosis.

Indexed as

Escherichia coli ProteinsAnimalsApoptosisBacterial ToxinsCytokinesEnterotoxinsG(M1) GangliosideImmunosuppressive AgentsLymphocyte ActivationLymphocyte Culture Test, MixedMiceMice, Inbred AKRMice, Inbred BALB CMice, Inbred C57BLMice, Inbred DBARecombinant ProteinsBacterial ToxinsCytokinesEnterotoxinsEscherichia coli ProteinsG(M1) Gangliosideheat-labile enterotoxin, E coliImmunosuppressive AgentsRecombinant Proteins

Identifiers

PMID9529046
PMCPMC108053
OpenAlexW2160576678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.